International Union of Pharmacology. LXVIII. Mammalian Bombesin Receptors: Nomenclature, Distribution, Pharmacology, Signaling, and Functions in Normal and Disease States
暂无分享,去创建一个
[1] A. Schally,et al. Biological effects and receptor binding affinities of new pseudononapeptide bombesin/GRP receptor antagonists with N-terminal D-Trp or D-Tpi. , 2009, International journal of peptide and protein research.
[2] J. Bali,et al. Synthesis of pseudo-peptide analogues of the C-terminal tetrapeptide of gastrin and evaluation of their biological activity on acid secretion. , 2009, International journal of peptide and protein research.
[3] M. Schubert,et al. Gastric secretion , 2008, Current opinion in gastroenterology.
[4] J. Crapo,et al. Bombesin-like peptides modulate alveolarization and angiogenesis in bronchopulmonary dysplasia. , 2007, American journal of respiratory and critical care medicine.
[5] G. Baldwin,et al. Phylogenetic analysis of the sequences of gastrin-releasing peptide and its receptors: Biological implications , 2007, Regulatory Peptides.
[6] L. Christiansen,et al. Evidence for the association of the S100β gene with low cognitive performance and dementia in the elderly , 2007, Molecular Psychiatry.
[7] R. Roesler,et al. Gastrin-releasing peptide receptor as a molecular target in experimental anticancer therapy. , 2007, Annals of oncology : official journal of the European Society for Medical Oncology.
[8] F. McGlone,et al. Chronic itch and chronic pain: Analogous mechanisms , 2007, Pain.
[9] J. Speakman,et al. Expression of neuromedin B in adipose tissue and its regulation by changes in energy balance. , 2007, Journal of molecular endocrinology.
[10] G. Baldwin,et al. Recombinant C-terminal fragments of the gastrin-releasing peptide precursor are bioactive. , 2007, Cancer letters.
[11] A. Schally,et al. Targeted therapy of breast and gynecological cancers with cytotoxic analogues of peptide hormones. , 2007, Molecular pharmaceutics.
[12] J. Reubi,et al. Overexpression of Gastrin-Releasing Peptide Receptors in Tumor-Associated Blood Vessels of Human Ovarian Neoplasms , 2007, Cellular oncology : the official journal of the International Society for Cellular Oncology.
[13] Yan-Gang Sun,et al. A gastrin-releasing peptide receptor mediates the itch sensation in the spinal cord , 2007, Nature.
[14] Timothy J. Hoffman,et al. In Vivo Evaluation and Small-Animal PET/CT of a Prostate Cancer Mouse Model Using 64Cu Bombesin Analogs: Side-by-Side Comparison of the CB-TE2A and DOTA Chelation Systems , 2007, Journal of Nuclear Medicine.
[15] Peter Hohenberger,et al. 68Ga-Labeled Bombesin Studies in Patients with Gastrointestinal Stromal Tumors: Comparison with 18F-FDG , 2007, Journal of Nuclear Medicine.
[16] S. Figueroa,et al. [64Cu-NOTA-8-Aoc-BBN(7-14)NH2] targeting vector for positron-emission tomography imaging of gastrin-releasing peptide receptor-expressing tissues , 2007, Proceedings of the National Academy of Sciences.
[17] E. Mintz,et al. Gastrin releasing peptide and neuropeptide Y exert opposing actions on circadian phase , 2007, Neuroscience Letters.
[18] Hui-jun Liu,et al. PPARα and AP-2α regulate bombesin receptor subtype 3 expression in ozone-stressed bronchial epithelial cells , 2007 .
[19] Å. Svensson,et al. Self reported skin morbidity and ethnicity: a population-based study in a Western community , 2007, BMC dermatology.
[20] E. Rozengurt,et al. Protein kinase D2 potentiates MEK/ERK/RSK signaling, c‐Fos accumulation and DNA synthesis induced by bombesin in Swiss 3T3 cells , 2007, Journal of cellular physiology.
[21] E. Ladenheim,et al. Capsaicin treatment differentially affects feeding suppression by bombesin-like peptides , 2007, Physiology & Behavior.
[22] T. Visser,et al. Radiolabelled regulatory peptides for imaging and therapy. , 2007, Anti-cancer agents in medicinal chemistry.
[23] Zul Merali,et al. Role of gastrin-releasing peptide and neuromedin B in anxiety and fear-related behavior , 2007, Behavioural Brain Research.
[24] J. Siegfried,et al. Gastrin-releasing peptide activates Akt through the epidermal growth factor receptor pathway and abrogates the effect of gefitinib. , 2007, Experimental cell research.
[25] Jill M. Siegfried,et al. Antitumor mechanisms of combined gastrin-releasing peptide receptor and epidermal growth factor receptor targeting in head and neck cancer , 2007, Molecular Cancer Therapeutics.
[26] F. Dalgard,et al. Are Itch and Chronic Pain Associated in Adults? Results of a Large Population Survey in Norway , 2007, Dermatology.
[27] G. Baldwin,et al. C-terminal fragments of the gastrin-releasing peptide precursor stimulate cell proliferation via a novel receptor. , 2007, Endocrinology.
[28] K. Haruma,et al. Bombesin prevents the atrophy of Peyer's patches and the dysfunction of M cells in rabbits receiving long-term parenteral nutrition. , 2007, JPEN. Journal of parenteral and enteral nutrition.
[29] R. Roesler,et al. Impairments of social behavior and memory after neonatal gastrin-releasing peptide receptor blockade in rats: Implications for an animal model of neurodevelopmental disorders , 2007, Neuropharmacology.
[30] F. Forrer,et al. Peptide receptor radionuclide therapy , 2007 .
[31] R. Gainetdinov,et al. Physiological roles of G protein-coupled receptor kinases and arrestins. , 2007, Annual review of physiology.
[32] A. Coran,et al. Bombesin stimulates enterocyte turnover following massive small bowel resection in a rat , 2007, Pediatric Surgery International.
[33] E. Krenning,et al. Novel 111In-labelled bombesin analogues for molecular imaging of prostate tumours , 2007, European Journal of Nuclear Medicine and Molecular Imaging.
[34] M. Eisenhut,et al. DOTA-PESIN, a DOTA-conjugated bombesin derivative designed for the imaging and targeted radionuclide treatment of bombesin receptor-positive tumours , 2007, European Journal of Nuclear Medicine and Molecular Imaging.
[35] L. Lénárd,et al. Neuromedin C microinjected into the amygdala inhibits feeding , 2007, Brain Research Bulletin.
[36] R. Valkema,et al. Peptide Receptor Radionuclide Therapy with radiolabelled somatostatin analogues in patients with somatostatin receptor positive tumours , 2007, Acta oncologica.
[37] A. Nunn,et al. Lutetium-177-labeled gastrin releasing peptide receptor binding analogs: a novel approach to radionuclide therapy. , 2006, The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of....
[38] R. Jensen,et al. Identification of Bombesin Receptor Subtype-Specific Ligands: Effect of N-Methyl Scanning, Truncation, Substitution, and Evaluation of Putative Reported Selective Ligands , 2006, Journal of Pharmacology and Experimental Therapeutics.
[39] A. Harada,et al. Activation of bombesin receptor subtype-3 stimulates adhesion of lung cancer cells. , 2006, Lung cancer.
[40] H. Anisman,et al. Bombesin Receptors as a Novel Anti-Anxiety Therapeutic Target: BB1 Receptor Actions on Anxiety through Alterations of Serotonin Activity , 2006, The Journal of Neuroscience.
[41] N. Sugimoto,et al. Neuropeptide-stimulated cell migration in prostate cancer cells is mediated by RhoA kinase signaling and inhibited by neutral endopeptidase , 2006, Oncogene.
[42] S. Schulz,et al. Immunohistochemical detection of bombesin receptor subtypes GRP-R and BRS-3 in human tumors using novel antipeptide antibodies , 2006, Virchows Archiv.
[43] R. Jensen,et al. In Vitro and in Vivo Antitumor Effects of Cytotoxic Camptothecin-Bombesin Conjugates Are Mediated by Specific Interaction with Cellular Bombesin Receptors , 2006, Journal of Pharmacology and Experimental Therapeutics.
[44] R. Roesler,et al. Opposite effects of low and high doses of the gastrin-releasing peptide receptor antagonist RC-3095 on memory consolidation in the hippocampus: Possible involvement of the GABAergic system , 2006, Peptides.
[45] G. Baldwin,et al. Gastrin-releasing peptide and cancer. , 2006, Biochimica et biophysica acta.
[46] I. Izquierdo,et al. Molecular mechanisms mediating gastrin-releasing peptide receptor modulation of memory consolidation in the hippocampus , 2006, Neuropharmacology.
[47] A. Schally,et al. Therapy of ovarian cancers with targeted cytotoxic analogs of bombesin, somatostatin, and luteinizing hormone-releasing hormone and their combinations , 2006, Proceedings of the National Academy of Sciences.
[48] Thangavel Arunachalam,et al. 177Lu-AMBA: Synthesis and characterization of a selective 177Lu-labeled GRP-R agonist for systemic radiotherapy of prostate cancer. , 2006, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[49] Xiang Li,et al. Wound repair and proliferation of bronchial epithelial cells enhanced by bombesin receptor subtype 3 activation , 2006, Peptides.
[50] N. Iwai,et al. Prevention of warm ischemic injury by neuropeptide bombesin in small bowel transplantation. , 2006, Transplantation proceedings.
[51] N. Iwai,et al. Neuroendocrine-immune modulation may be useful for allograft-specific immunosuppression in small bowel transplantation. , 2006, Transplantation proceedings.
[52] N. Iwai,et al. FK506 induces the atrophy of enteric ganglia in small bowel transplantation, which can be prevented by the neuropeptide bombesin. , 2006, Transplantation proceedings.
[53] I. Izquierdo,et al. A role for hippocampal gastrin-releasing peptide receptors in extinction of aversive memory , 2006, Neuroreport.
[54] K. Wada,et al. Bombesin inhibits alveolarization and promotes pulmonary fibrosis in newborn mice. , 2006, American journal of respiratory and critical care medicine.
[55] Alfred Martinez. A new family of angiogenic factors. , 2006, Cancer letters.
[56] M. Perry,et al. Evaluation of combined (177)Lu-DOTA-8-AOC-BBN (7-14)NH(2) GRP receptor-targeted radiotherapy and chemotherapy in PC-3 human prostate tumor cell xenografted SCID mice. , 2006, Cancer biotherapy & radiopharmaceuticals.
[57] R. Benya,et al. Consequence of gastrin-releasing peptide receptor activation in a human colon cancer cell line: a proteomic approach. , 2006, Journal of proteome research.
[58] A. Safavy,et al. Single-drug multiligand conjugates: synthesis and preliminary cytotoxicity evaluation of a paclitaxel-dipeptide "scorpion" molecule. , 2006, Bioconjugate chemistry.
[59] R. Jensen,et al. The Src family kinase, Lyn, is activated in pancreatic acinar cells by gastrointestinal hormones/neurotransmitters and growth factors which stimulate its association with numerous other signaling molecules. , 2006, Biochimica et biophysica acta.
[60] C. Nanni,et al. 18F-DOPA PET/CT and neuroendocrine tumours , 2006, European Journal of Nuclear Medicine and Molecular Imaging.
[61] R. Roesler,et al. Gastrin-releasing peptide receptor as a molecular target for psychiatric and neurological disorders. , 2006, CNS & neurological disorders drug targets.
[62] Eduard Schreibmann,et al. 18F-labeled bombesin analogs for targeting GRP receptor-expressing prostate cancer. , 2006, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[63] P. Pohlmann,et al. A phase I trial of the bombesin/gastrin-releasing peptide (BN/GRP) antagonist RC3095 in patients with advanced solid malignancies , 2006, Investigational New Drugs.
[64] H. Ohki‐Hamazaki,et al. Disruption of neuromedin B receptor gene results in dysregulation of the pituitary-thyroid axis. , 2006, Journal of molecular endocrinology.
[65] B. McEwen,et al. Diurnal regulation of the gastrin‐releasing peptide receptor in the mouse circadian clock , 2006, The European journal of neuroscience.
[66] A. Schally,et al. Targeted cytotoxic bombesin analog AN-215 effectively inhibits experimental human breast cancers with a low induction of multi-drug resistance proteins. , 2005, Endocrine-related cancer.
[67] N. Iwai,et al. Preoperative bombesin administration can protect the rat small bowel allograft from ischemic reperfusion injury. , 2005, Journal of pediatric surgery.
[68] C. Vagianos,et al. Effect of bombesin and neurotensin on gut barrier function in partially hepatectomized rats. , 2005, World journal of gastroenterology.
[69] Y. Wong,et al. Gq-Mediated Activation of c-Jun N-Terminal Kinase by the Gastrin-Releasing Peptide-Preferring Bombesin Receptor Is Inhibited upon Costimulation of the Gs-Coupled Dopamine D1 Receptor in COS-7 Cells , 2005, Molecular Pharmacology.
[70] R. Massari,et al. Fast cancer uptake of 99mTc-labelled bombesin (99mTc BN1). , 2005, In vivo.
[71] C. Albanese,et al. Bombesin regulates cyclin D1 expression through the early growth response protein Egr-1 in prostate cancer cells. , 2005, Cancer research.
[72] T. Hoffman,et al. Radiolabeled peptide conjugates for targeting of the bombesin receptor superfamily subtypes. , 2005, Nuclear medicine and biology.
[73] K. Yonemori,et al. Pro‐gastrin–releasing peptide as a factor predicting the incidence of brain metastasis in patients with small cell lung carcinoma with limited disease receiving prophylactic cranial irradiation , 2005, Cancer.
[74] A. Schally,et al. Antagonists of growth hormone releasing hormone (GHRH) and of bombesin/gastrin releasing peptide (BN/GRP) suppress the expression of VEGF, bFGF, and receptors of the EGF/HER family in PC‐3 and DU‐145 human androgen‐independent prostate cancers , 2005, The Prostate.
[75] J. Reubi,et al. Gastrin-releasing peptide receptors in normal and neoplastic human uterus: involvement of multiple tissue compartments. , 2005, The Journal of clinical endocrinology and metabolism.
[76] T. Schlott,et al. Expression of gastrin releasing Peptide receptor in renal cell carcinomas: a potential function for the regulation of neoangiogenesis and microvascular perfusion. , 2005, The Journal of urology.
[77] R. Benya,et al. Transient upregulation of GRP and its receptor critically regulate colon cancer cell motility during remodeling. , 2005, American journal of physiology. Gastrointestinal and liver physiology.
[78] Sarah Glover,et al. Neuromedin B and its receptor are mitogens in both normal and malignant epithelial cells lining the colon. , 2005, American journal of physiology. Gastrointestinal and liver physiology.
[79] J. Siegfried,et al. Gastrin-releasing peptide receptor mediates activation of the epidermal growth factor receptor in lung cancer cells. , 2005, Neoplasia.
[80] K. Wada,et al. The design of a new potent and selective ligand for the orphan bombesin receptor subtype 3 (BRS3) , 2005, Journal of peptide science : an official publication of the European Peptide Society.
[81] B. Bonaz,et al. Bombesin receptor subtype-3 is expressed by the enteric nervous system and by interstitial cells of Cajal in the rat gastrointestinal tract , 2005, Cell and Tissue Research.
[82] R. Jensen,et al. Identification of key amino acids in the gastrin-releasing peptide receptor (GRPR) responsible for high affinity binding of gastrin-releasing peptide (GRP). , 2005, Biochemical pharmacology.
[83] A. Schally,et al. Antagonists of bombesin/gastrin-releasing peptide decrease the expression of angiogenic and anti-apoptotic factors in human glioblastoma , 2005, Anti-cancer drugs.
[84] K. Wada,et al. Immunohistochemical localization of gastrin-releasing peptide receptor in the mouse brain , 2005, Brain Research.
[85] R. Baudinette,et al. An immunomodulator used to protect young in the pouch of the Tammar wallaby, Macropus eugenii , 2005, The FEBS journal.
[86] C. Vagianos,et al. Bombesin and Neurotensin Reduce Endotoxemia, Intestinal Oxidative Stress, and Apoptosis in Experimental Obstructive Jaundice , 2005, Annals of surgery.
[87] C. Bouchard,et al. Neuromedin beta: a strong candidate gene linking eating behaviors and susceptibility to obesity. , 2004, The American journal of clinical nutrition.
[88] G. Baldwin,et al. Stimulation of proliferation and migration of a colorectal cancer cell line by amidated and glycine-extended gastrin-releasing peptide via the same receptor. , 2004, Biochemical pharmacology.
[89] Jiehua Zhou,et al. Targeting gastrin-releasing peptide receptors for cancer treatment , 2004, Anti-cancer drugs.
[90] C. Lamers,et al. Gastrin releasing peptide receptor expression is decreased in patients with Crohn’s disease but not in ulcerative colitis , 2004, Journal of Clinical Pathology.
[91] G. Baldwin,et al. Developmental expression and biological activity of gastrin-releasing peptide and its receptors in the kidney. , 2004, American journal of physiology. Renal physiology.
[92] R. Jensen,et al. Development of Bombesin Analogs with Conformationally Restricted Amino Acid Substitutions with Enhanced Selectivity for the Orphan Receptor Human Bombesin Receptor Subtype 3 , 2004, Journal of Pharmacology and Experimental Therapeutics.
[93] A. Schally,et al. Chemotherapy targeted to cancers through tumoral hormone receptors , 2004, Trends in Endocrinology & Metabolism.
[94] J. Grider. Gastrin-releasing peptide is a modulatory neurotransmitter of the descending phase of the peristaltic reflex. , 2004, American journal of physiology. Gastrointestinal and liver physiology.
[95] E. Corazziari,et al. Detection of colon cancer with 99mTc-labeled bombesin derivative (99mTc-leu13-BN1). , 2004, Cancer biotherapy & radiopharmaceuticals.
[96] G. de Vincentis,et al. Role of 99mTc-bombesin scan in diagnosis and staging of prostate cancer. , 2004, Cancer biotherapy & radiopharmaceuticals.
[97] M. Reitman,et al. Characterization of the bombesin-like peptide receptor family in primates. , 2004, Genomics.
[98] E. Rozengurt,et al. Insulin reduces the requirement for EGFR transactivation in bombesin-induced DNA synthesis. , 2004, Biochemical and biophysical research communications.
[99] K. Wada,et al. Functions of pancreatic beta cells and adipocytes in bombesin receptor subtype-3-deficient mice. , 2004, Biochemical and biophysical research communications.
[100] R. Jensen,et al. Development of High Affinity Camptothecin-Bombesin Conjugates That Have Targeted Cytotoxicity for Bombesin Receptor-containing Tumor Cells* , 2004, Journal of Biological Chemistry.
[101] C. Vagianos,et al. Experimental obstructive jaundice disrupts intestinal mucosal barrier by altering occludin expression: beneficial effect of bombesin and neurotensin. , 2004, Journal of the American College of Surgeons.
[102] E. Rozengurt,et al. Protein Kinase D Potentiates DNA Synthesis Induced by Gq-coupled Receptors by Increasing the Duration of ERK Signaling in Swiss 3T3 Cells* , 2004, Journal of Biological Chemistry.
[103] R. Benya,et al. Phosphorylation of focal adhesion kinase tyrosine 397 critically mediates gastrin‐releasing peptide's morphogenic properties , 2004, Journal of cellular physiology.
[104] T. Moody,et al. Bombesin-like peptides and associated receptors within the brain: distribution and behavioral implications , 2004, Peptides.
[105] H. Ohki‐Hamazaki,et al. Leptin resistance and enhancement of feeding facilitation by melanin-concentrating hormone in mice lacking bombesin receptor subtype-3. , 2004, Diabetes.
[106] R. Jensen,et al. Diagnostic uses of radiolabelled somatostatin receptor analogues in gastroenteropancreatic endocrine tumours. , 2004, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.
[107] I. Izquierdo,et al. Bombesin/gastrin‐releasing peptide receptors in the basolateral amygdala regulate memory consolidation , 2004, The European journal of neuroscience.
[108] E. Cartwright,et al. Gastrin releasing peptide and gastrin releasing peptide receptor expression in gastrointestinal carcinoid tumours , 2004, Journal of Clinical Pathology.
[109] A. Bajo,et al. Bombesin antagonists inhibit proangiogenic factors in human experimental breast cancers , 2004, British Journal of Cancer.
[110] J. Siegfried,et al. Lung cancer-derived bombesin-like peptides down-regulate the generation and function of human dendritic cells , 2003, Journal of Neuroimmunology.
[111] R. Jensen,et al. Importance of Amino Acids of the Central Portion of the Second Intracellular Loop of the Gastrin-Releasing Peptide Receptor for Phospholipase C Activation, Internalization, and Chronic Down-Regulation , 2003, Journal of Pharmacology and Experimental Therapeutics.
[112] N. Matsuura,et al. Transactivation of epidermal growth factor receptor after heparin‐binding epidermal growth factor‐like growth factor shedding in the migration of prostate cancer cells promoted by bombesin , 2003, The Prostate.
[113] T. Hoffman,et al. Gastrin releasing peptide (GRP) receptor targeted radiopharmaceuticals: a concise update. , 2003, Nuclear medicine and biology.
[114] E. Rozengurt,et al. Galardin (GM 6001), a broad-spectrum matrix metalloproteinase inhibitor, blocks bombesin- and LPA-induced EGF receptor transactivation and DNA synthesis in rat-1 cells. , 2003, Experimental cell research.
[115] M. Morales,et al. Thyrotropin Secretagogues Reduce Rat Pituitary Neuromedin B, a Local Thyrotropin Release Inhibitor , 2003, Experimental biology and medicine.
[116] X. Qu,et al. Activation of extracellular signal-regulated kinase mediates bombesin-induced mitogenic responses in prostate cancer cells. , 2003, Cellular signalling.
[117] J. Battey,et al. Agonist- and protein kinase C-induced phosphorylation have similar functional consequences for gastrin-releasing peptide receptor signaling via Gq. , 2003, Molecular pharmacology.
[118] J. Siegfried,et al. Mitogenic effects of gastrin-releasing peptide in head and neck squamous cancer cells are mediated by activation of the epidermal growth factor receptor , 2003, Oncogene.
[119] C. Wiedermann,et al. Agonist function of the neurokinin receptor antagonist, [d-Arg1,d-Phe5,d-Trp7,9,Leu11]substance P, in monocytes , 2003, Regulatory Peptides.
[120] Y. Miller,et al. Bombesin-like peptides and mast cell responses: relevance to bronchopulmonary dysplasia? , 2003, American journal of respiratory and critical care medicine.
[121] P. Maycox,et al. The distribution of the orphan bombesin receptor subtype-3 in the rat cns , 2003, Neuroscience.
[122] R. Jensen,et al. Nonpeptide gastrin releasing peptide receptor antagonists inhibit the proliferation of lung cancer cells. , 2003, European journal of pharmacology.
[123] M. R. Hellmich,et al. Bombesin stimulates nuclear factor kappa B activation and expression of proangiogenic factors in prostate cancer cells. , 2003, Cancer research.
[124] K. Ui-Tei,et al. Molecular cloning and characterization of avian bombesin‐like peptide receptors: new tools for investigating molecular basis for ligand selectivity , 2003, British journal of pharmacology.
[125] R. Benya,et al. Increased frequency of gastrin‐releasing peptide receptor gene mutations during colon‐adenocarcinoma progression , 2003, Molecular carcinogenesis.
[126] H. Sarau,et al. The neuromedin B receptor antagonist, BIM‐23127, is a potent antagonist at human and rat urotensin‐II receptors , 2003, British journal of pharmacology.
[127] B. Yeğen. Bombesin-like peptides: candidates as diagnostic and therapeutic tools. , 2003, Current pharmaceutical design.
[128] H. Kessler,et al. Design of selective peptidomimetic agonists for the human orphan receptor BRS-3. , 2003, Journal of medicinal chemistry.
[129] R. Valkema,et al. Radiolabelled peptides for tumour therapy: current status and future directions , 2003, European Journal of Nuclear Medicine and Molecular Imaging.
[130] K. Wada,et al. Stress-induced impairment of inhibitory avoidance learning in female neuromedin B receptor-deficient mice , 2003, Physiology & Behavior.
[131] T. Ortiga-Carvalho,et al. The autocrine/paracrine regulation of thyrotropin secretion. , 2003, Thyroid : official journal of the American Thyroid Association.
[132] G. Loudos,et al. [99mTc]Demobesin 1, a novel potent bombesin analogue for GRP receptor-targeted tumour imaging , 2003, European Journal of Nuclear Medicine and Molecular Imaging.
[133] K. Wada,et al. Bombesin receptor subtype-3 modulates plasma insulin concentration , 2003, Peptides.
[134] R. Jensen,et al. Neuropeptides as autocrine growth factors in cancer cells. , 2003, Current pharmaceutical design.
[135] Eric R. Kandel,et al. Identification of a Signaling Network in Lateral Nucleus of Amygdala Important for Inhibiting Memory Specifically Related to Learned Fear , 2002, Cell.
[136] T. Visser,et al. Preclinical comparison of (111)In-labeled DTPA- or DOTA-bombesin analogs for receptor-targeted scintigraphy and radionuclide therapy. , 2002, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[137] G. Pacini,et al. Islet function phenotype in gastrin-releasing peptide receptor gene-deficient mice. , 2002, Endocrinology.
[138] K. Wada,et al. Restraint stress impaired maternal behavior in female mice lacking the neuromedin B receptor (NMB-R) gene , 2002, Neuroscience Letters.
[139] J. Nathan,et al. Neurohormonal control of pancreatic exocrine secretion , 2002, Current opinion in gastroenterology.
[140] J. Battey,et al. Disruptions in feeding and body weight control in gastrin-releasing peptide receptor deficient mice. , 2002, The Journal of endocrinology.
[141] Horst Kessler,et al. Systematic optimization of a lead‐structure identities for a selective short peptide agonist for the human orphan receptor BRS‐3 , 2002, Journal of peptide science : an official publication of the European Peptide Society.
[142] L. V. D. van der Ploeg,et al. Molecular basis of the pharmacological difference between rat and human bombesin receptor subtype-3 (BRS-3). , 2002, Biochemistry.
[143] R. Jensen,et al. Molecular basis of the selectivity of gastrin-releasing peptide receptor for gastrin-releasing peptide. , 2002, Molecular pharmacology.
[144] D. Chung,et al. Gastrin-Releasing Peptide Is a Growth Factor for Human Neuroblastomas , 2002, Annals of surgery.
[145] R. Benya,et al. Contribution of gastrin-releasing peptide and its receptor to villus development in the murine and human gastrointestinal tract , 2002, Mechanisms of Development.
[146] H. Ogura,et al. Modulation of 5‐HT system in mice with a targeted disruption of neuromedin B receptor , 2002, Journal of neuroscience research.
[147] J. Reubi,et al. Bombesin Receptor Subtypes in Human Cancers: Detection with the Universal Radioligand 125I-[d-TYR6, β-ALA11, PHE13, NLE14] Bombesin(6–14) , 2002 .
[148] J. Siegfried,et al. Gastrin-releasing peptide receptor-mediated autocrine growth in squamous cell carcinoma of the head and neck. , 2002, Journal of the National Cancer Institute.
[149] H. Anisman,et al. Role of bombesin-related peptides in the mediation or integration of the stress response , 2002, Cellular and Molecular Life Sciences CMLS.
[150] M. Singer,et al. Central and peripheral neural control of pancreatic exocrine secretion. , 2001, Journal of physiology and pharmacology : an official journal of the Polish Physiological Society.
[151] R. Jensen,et al. Molecular Basis for Selectivity of High Affinity Peptide Antagonists for the Gastrin-releasing Peptide Receptor* , 2001, The Journal of Biological Chemistry.
[152] E. Rozengurt,et al. EGF receptor function is required in late G(1) for cell cycle progression induced by bombesin and bradykinin. , 2001, American journal of physiology. Cell physiology.
[153] G. Frank,et al. Reduced gastrin releasing peptide in cerebrospinal fluid after recovery from bulimia nervosa , 2001, Appetite.
[154] Christopher Haslett,et al. Bombesin and Substance P Analogues Differentially Regulate G-protein Coupling to the Bombesin Receptor , 2001, The Journal of Biological Chemistry.
[155] C. Beglinger,et al. Regulation of gastric function by endogenous gastrin releasing peptide in humans: studies with a specific gastrin releasing peptide receptor antagonist , 2001, Gut.
[156] R. Benya,et al. The case for gastrin-releasing peptide acting as a morphogen when it and its receptor are aberrantly expressed in cancer , 2001, Peptides.
[157] K. Kiura,et al. Complementary roles of pro-gastrin-releasing peptide (ProGRP) and neuron specific enolase (NSE) in diagnosis and prognosis of small-cell lung cancer (SCLC). , 2001, Lung cancer.
[158] J. Knezetic,et al. Receptors and Ligands for Autocrine Growth Pathways Are Up-regulated When Pancreatic Cancer Cells Are Adapted to Serum-Free Culture , 2001, Pancreas.
[159] R. Jensen,et al. Rational Design of a Peptide Agonist That Interacts Selectively with the Orphan Receptor, Bombesin Receptor Subtype 3* , 2001, The Journal of Biological Chemistry.
[160] K. Wada,et al. Female gastrin-releasing peptide receptor (GRP-R)-deficient mice exhibit altered social preference for male conspecifics: implications for GRP/GRP-R modulation of GABAergic function , 2001, Brain Research.
[161] S. Ferguson,et al. Evolving concepts in G protein-coupled receptor endocytosis: the role in receptor desensitization and signaling. , 2001, Pharmacological reviews.
[162] D. Xiao,et al. The human gastrin-releasing peptide receptor gene structure, its tissue expression and promoter. , 2001, Gene.
[163] C. Beglinger,et al. Blockade of GRP receptors inhibits gastric emptying and gallbladder contraction but accelerates small intestinal transit. , 2001, Gastroenterology.
[164] R. Jensen,et al. A bombesin receptor subtype-3 peptide increases nuclear oncogene expression in a MEK-1 dependent manner in human lung cancer cells. , 2001, European journal of pharmacology.
[165] David H. Coy,et al. Tyrosine 220 in the 5th Transmembrane Domain of the Neuromedin B Receptor Is Critical for the High Selectivity of the Peptoid Antagonist PD168368* , 2001, The Journal of Biological Chemistry.
[166] R. Jensen,et al. Nonpeptide neuromedin B receptor antagonists inhibit the proliferation of C6 cells. , 2000, European journal of pharmacology.
[167] H. Friess,et al. Bombesin Receptors in Distinct Tissue Compartments of Human Pancreatic Diseases , 2000, Laboratory Investigation.
[168] A. Schally,et al. in vivo inhibition of PC‐3 human androgen‐independent prostate cancer by a targeted cytotoxic bombesin analogue, AN‐215 , 2000, International journal of cancer.
[169] J. Torday,et al. Bombesin-like peptide and receptors in lung injury models: diverse gene expression, similar function☆,☆☆ 1 1 ☆☆ We are deeply grateful to Professor Vittorio Erspamer, whose vision and life’s work paved the way for these studies. , 2000, Peptides.
[170] K. Wada,et al. Reduced GLP-1 and insulin responses and glucose intolerance after gastric glucose in GRP receptor-deleted mice. , 2000, American journal of physiology. Endocrinology and metabolism.
[171] Y. Taché,et al. Bombesin and the brain-gut axis☆,1 , 2000, Peptides.
[172] Hiroko Ohki-Hamazaki. Neuromedin B , 2000, Progress in Neurobiology.
[173] C. Beglinger,et al. Blockade of GRP receptors inhibits gastric emptying and gallbladder contraction but accelerates small intestinal transit in humans , 2000, Regulatory Peptides.
[174] A. Schally,et al. Peptide analogs in the therapy of prostate cancer , 2000, The Prostate.
[175] E. Rozengurt,et al. [d-Arg1,d-Trp5,7,9,Leu11]Substance P Inhibits Bombesin-induced Mitogenic Signal Transduction Mediated by Both Gq and G12 in Swiss 3T3 Cells* , 2000, The Journal of Biological Chemistry.
[176] R. Benya,et al. Characterization of gastrin-releasing peptide and its receptor aberrantly expressed by human colon cancer cell lines. , 2000, Molecular pharmacology.
[177] R. Jensen,et al. Two amino acids in the sixth transmembrane segment of the mouse gastrin-releasing peptide receptor are important for receptor activation. , 2000, The Journal of pharmacology and experimental therapeutics.
[178] K. Wada,et al. Male mice lacking the gastrin-releasing peptide receptor (GRP-R) display elevated preference for conspecific odors and increased social investigatory behaviors , 2000, Brain Research.
[179] R. Benya,et al. Gastrin-releasing peptide is a mitogen and a morphogen in murine colon cancer. , 2000, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.
[180] A. Schally,et al. The presence of receptors for bombesin/GRP and mRNA for three receptor subtypes in human ovarian epithelial cancers , 2000, Regulatory Peptides.
[181] Z. Szallasi,et al. Effect of a tyrosine 155 to phenylalanine mutation of protein kinase cdelta on the proliferative and tumorigenic properties of NIH 3T3 fibroblasts. , 2000, Carcinogenesis.
[182] A. Schally,et al. Presence of receptors for bombesin/gastrin‐releasing peptide and mRNA for three receptor subtypes in human prostate cancers , 2000, The Prostate.
[183] R. Jensen,et al. Molecular organization of the mouse gastrin-releasing peptide receptor gene and its promoter. , 2000, Gene.
[184] H. Ohki‐Hamazaki,et al. Differential effects of social isolation upon body weight, food consumption, and responsiveness to novel and social environment in bombesin receptor subtype-3 (BRS-3) deficient mice , 2000, Physiology & Behavior.
[185] S. Yamashita,et al. Mutation in Bombesin Receptor Subtype-3 Gene is not a Major Cause of Obesity in the Japanese , 2000, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.
[186] J. Battey,et al. Phosphorylation Uncouples the Gastrin-releasing Peptide Receptor from Gq * , 1999, The Journal of Biological Chemistry.
[187] J. Primrose,et al. Bombesin family receptor and ligand gene expression in human colorectal cancer and normal mucosa , 1999, British Journal of Cancer.
[188] J C Reubi,et al. Gastrin-releasing peptide receptors in non-neoplastic and neoplastic human breast. , 1999, The American journal of pathology.
[189] J. Torday,et al. Bombesin-like peptides and receptors in normal fetal baboon lung: roles in lung growth and maturation. , 1999, American journal of physiology. Lung cellular and molecular physiology.
[190] S. Larson,et al. Phase I and imaging trial of a monoclonal antibody directed against gastrin-releasing peptide in patients with lung cancer. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.
[191] J. Siegfried,et al. Evidence for autocrine actions of neuromedin B and gastrin-releasing peptide in non-small cell lung cancer. , 1999, Pulmonary pharmacology & therapeutics.
[192] H. Anisman,et al. Role of bombesin-related peptides in the control of food intake , 1999, Neuropeptides.
[193] R. Jensen,et al. Comparative pharmacology of the nonpeptide neuromedin B receptor antagonist PD 168368. , 1999, The Journal of pharmacology and experimental therapeutics.
[194] A. Shulkes,et al. Molecular cloning, genomic organization and selective expression of bombesin receptor subtype 3 in the sheep hypothalamus and pituitary. , 1999, Journal of molecular endocrinology.
[195] N. Sunaga,et al. Serum Pro-Gastrin-Releasing Peptide Is a Useful Marker for Treatment Monitoring and Survival in Small-Cell Lung Cancer , 1999, Oncology.
[196] R. Jensen,et al. An aspartate residue at the extracellular boundary of TMII and an arginine residue in TMVII of the gastrin-releasing peptide receptor interact to facilitate heterotrimeric G protein coupling. , 1999, Biochemistry.
[197] J P Vincent,et al. Neurotensin and neurotensin receptors. , 1999, Trends in pharmacological sciences.
[198] H. Ohki‐Hamazaki,et al. Hyperresponsiveness to Palatable and Aversive Taste Stimuli in Genetically Obese (Bombesin Receptor Subtype-3–Deficient) Mice , 1999, Physiology & Behavior.
[199] A. Schally,et al. Cancer chemotherapy based on targeting of cytotoxic peptide conjugates to their receptors on tumors. , 1999, European journal of endocrinology.
[200] R. Jensen,et al. Pharmacology and cell biology of the bombesin receptor subtype 4 (BB4-R). , 1999, Biochemistry.
[201] R. Jensen,et al. The Bombesin Receptor Subtypes Have Distinct G Protein Specificities* , 1999, The Journal of Biological Chemistry.
[202] R. Benya,et al. Aberrant expression of gastrin-releasing peptide and its receptor by well-differentiated colon cancers in humans. , 1999, American journal of physiology. Gastrointestinal and liver physiology.
[203] J. Fehrentz,et al. Syntheses and biological activities of potent bombesin receptor antagonists. , 1999, The journal of peptide research : official journal of the American Peptide Society.
[204] J C Reubi,et al. Gastrin-releasing peptide receptors in the human prostate: relation to neoplastic transformation. , 1999, Cancer research.
[205] R. Benya,et al. Characterization of gastrin-releasing peptide receptors aberrantly expressed by non-antral gastric adenocarcinomas , 1999, Peptides.
[206] H. Ogura,et al. Functional Properties of Two Bombesin-Like Peptide Receptors Revealed by the Analysis of Mice Lacking Neuromedin B Receptor , 1999, The Journal of Neuroscience.
[207] T. Moody,et al. Bombesin activates MAP kinase in non-small cell lung cancer cells , 1999, Peptides.
[208] E. Vizi,et al. Role of Different Bombesin Receptor Subtypes Mediating Contractile Activity in Cat Upper Gastrointestinal Tract , 1998, Peptides.
[209] J. Fehrentz,et al. Comparative Study of In Vitro and In Vivo Activities of Bombesin Pseudopeptide Analogs Modified on the C-Terminal Dipeptide Fragment , 1998, Peptides.
[210] E. Rozengurt. Signal transduction pathways in the mitogenic response to G protein–coupled neuropeptide receptor agonists , 1998, Journal of cellular physiology.
[211] A. Schonbrunn,et al. Role of receptor and protein kinase C activation in the internalization of the gastrin-releasing peptide receptor. , 1998, Molecular pharmacology.
[212] J. Chayvialle,et al. Effects of neurotransmitters, gut hormones, and inflammatory mediators on mucus discharge in rat colon. , 1998, American journal of physiology. Gastrointestinal and liver physiology.
[213] R. Jensen,et al. Pharmacology and intracellular signaling mechanisms of the native human orphan receptor BRS-3 in lung cancer cells. , 1998, The Journal of pharmacology and experimental therapeutics.
[214] R. A. Lewthwaite,et al. PD 176252--the first high affinity non-peptide gastrin-releasing peptide (BB2) receptor antagonist. , 1998, Bioorganic & medicinal chemistry letters.
[215] B. Yoder,et al. Bombesin-like peptide mediates lung injury in a baboon model of bronchopulmonary dysplasia. , 1998, The Journal of clinical investigation.
[216] A. Schally,et al. Growth hormone-releasing hormone antagonist MZ-5-156 inhibits growth of DU-145 human androgen-independent prostate carcinoma in nude mice and suppresses the levels and mRNA expression of insulin-like growth factor II in tumors. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[217] Mark Akeson,et al. Four Amino Acid Residues Are Critical for High Affinity Binding of Neuromedin B to the Neuromedin B Receptor* , 1998, The Journal of Biological Chemistry.
[218] O. Ziv,et al. Design, synthesis, and biological activities of potent and selective somatostatin analogues incorporating novel peptoid residues. , 1998, Journal of medicinal chemistry.
[219] M. Takeyama,et al. Growth stimulation of normal melanocytes and nevocellular nevus cells by gastrin releasing peptide (GRP). , 1998, Journal of dermatological science.
[220] J. Battey,et al. Ability of Various Bombesin Receptor Agonists and Antagonists to Alter Intracellular Signaling of the Human Orphan Receptor BRS-3* , 1998, The Journal of Biological Chemistry.
[221] R. Jensen,et al. Structure and chromosomal localization of the mouse bombesin receptor subtype 3 gene. , 1998, Gene.
[222] R. Jensen,et al. Neuromedin B activates phospholipase D through both PKC-dependent and PKC-independent mechanisms. , 1998, Biochimica et biophysica acta.
[223] P. Szekeres,et al. The relationship between agonist intrinsic activity and the rate of endocytosis of muscarinic receptors in a human neuroblastoma cell line. , 1998, Molecular pharmacology.
[224] R. Jensen,et al. Loss of bombesin-induced feeding suppression in gastrin-releasing peptide receptor-deficient mice. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[225] A. Schally,et al. Inhibition of the growth of caki‐I human renal adenocarcinoma in Vivo by luteinizing hormone‐releasing hormone antagonist cetrorelix, somatostatin analog RC‐160, and bombesin antagonist RC‐3940‐II , 1998, Cancer.
[226] H. Nishino,et al. Mammalian bombesin receptors are coupled to multiple signal transduction pathways in pancreatic acini. , 1998, American journal of physiology. Gastrointestinal and liver physiology.
[227] R. Jensen,et al. Identification of a unique ligand which has high affinity for all four bombesin receptor subtypes. , 1998, European journal of pharmacology.
[228] E. Duzic,et al. [d-Arg1,d-Phe5,d-Trp7,9,Leu11]Substance P Acts as a Biased Agonist toward Neuropeptide and Chemokine Receptors* , 1998, The Journal of Biological Chemistry.
[229] R. Benya,et al. Location and Characterization of the Human GRP Receptor Expressed by Gastrointestinal Epithelial Cells , 1997, Peptides.
[230] R. Jensen,et al. Neuromedin B receptor activation causes tyrosine phosphorylation of p125FAK by a phospholipase C independent mechanism which requires p21rho and integrity of the actin cytoskeleton. , 1997, Biochemistry.
[231] H. Ogura,et al. Mice lacking bombesin receptor subtype-3 develop metabolic defects and obesity , 1997, Nature.
[232] R. Jensen,et al. Discovery of a High Affinity Radioligand for the Human Orphan Receptor, Bombesin Receptor Subtype 3, Which Demonstrates That It Has a Unique Pharmacology Compared with Other Mammalian Bombesin Receptors* , 1997, The Journal of Biological Chemistry.
[233] H. Ogura,et al. Generation and characterization of mice lacking gastrin-releasing peptide receptor. , 1997, Biochemical and biophysical research communications.
[234] F. Flynn. Bombesin Receptor Antagonists Block the Effects of Exogenous Bombesin but Not of Nutrients on Food Intake , 1997, Physiology & Behavior.
[235] L. Slice,et al. Bombesin-induced gastrin release from canine G cells is stimulated by Ca2+ but not by protein kinase C, and is enhanced by disruption of rho/cytoskeletal pathways. , 1997, The Journal of clinical investigation.
[236] J. Siegfried,et al. Expression of mRNA for gastrin-releasing peptide receptor by human bronchial epithelial cells. Association with prolonged tobacco exposure and responsiveness to bombesin-like peptides. , 1997, American journal of respiratory and critical care medicine.
[237] P. Boden,et al. Construction of chimeric human bombesin receptors to identify neuromedin B and gastrin-releasing peptide receptor binding sites. , 1997, Biochemical Society transactions.
[238] H. Ohki‐Hamazaki,et al. Cloning and expression of the neuromedin B receptor and the third subtype of bombesin receptor genes in the mouse , 1997, Brain Research.
[239] R. Jensen,et al. Identification of Four Amino Acids in the Gastrin-releasing Peptide Receptor That Are Required for High Affinity Agonist Binding* , 1997, The Journal of Biological Chemistry.
[240] J. Mulshine,et al. Antitumor activity of a monoclonal antibody directed against gastrin-releasing peptide in patients with small cell lung cancer. , 1997, Chest.
[241] M. Sharif,et al. Functional expression of bombesin receptor in most adult and pediatric human glioblastoma cell lines; role in mitogenesis and in stimulating the mitogen-activated protein kinase pathway , 1997, Molecular and Cellular Endocrinology.
[242] M. Sporn. Growth factors and cytokines in health and disease , 1997 .
[243] R. Jensen,et al. The gastrin-releasing peptide receptor is differentially coupled to adenylate cyclase and phospholipase C in different tissues. , 1997, Biochimica et biophysica acta.
[244] R. Jensen,et al. Effect of gastrin-releasing peptide receptor number on receptor affinity, coupling, degradation, and modulation. , 1997, Molecular pharmacology.
[245] N. Jones,et al. Differential control of cyclins D1 and D3 and the cdk inhibitor p27Kip1 by diverse signalling pathways in Swiss 3T3 cells , 1997, Oncogene.
[246] R. Jordan,et al. PD 165929 - The First High Affinity Non-Peptide Neuromedin-B (NMB) Receptor Selective Antagonist. , 1997 .
[247] D. Coy,et al. Role of vagal fibers and bombesin/gastrin-releasing peptide-neurons in distention-induced gastrin release in rats , 1997, Regulatory Peptides.
[248] J. Polak,et al. Pituitary neuromedin B content in experimental fasting and diabetes mellitus and correlation with thyrotropin secretion. , 1997, Metabolism: clinical and experimental.
[249] R. Jensen,et al. Characterization of bombesin binding sites in the rat stomach. , 1997, European journal of pharmacology.
[250] T. Moody,et al. BW1023U90: A new GRP receptor antagonist for small-cell lung cancer cells , 1996, Peptides.
[251] T. Seufferlein,et al. Dissociation of mitogen-activated protein kinase activation from p125 focal adhesion kinase tyrosine phosphorylation in Swiss 3T3 cells stimulated by bombesin, lysophosphatidic acid, and platelet-derived growth factor. , 1996, Molecular biology of the cell.
[252] R. Jordan,et al. PD 165929 — the first high affinity non-peptide neuromedin-B (NMB) receptor selective antagonist , 1996 .
[253] R. Feldman,et al. Discovery of high affinity bombesin receptor subtype 3 agonists. , 1996, Molecular pharmacology.
[254] M. Kane,et al. Clinical correlates of bombesin-like peptide receptor subtype expression in human lung cancer cells. , 1996, Lung cancer.
[255] E. Rozengurt,et al. Bombesin, Bradykinin, Vasopressin, and Phorbol Esters Rapidly and Transiently Activate Src Family Tyrosine Kinases in Swiss 3T3 Cells , 1996, The Journal of Biological Chemistry.
[256] Y. Wang,et al. Agonist binding and protein kinase C activation stimulate phosphorylation of the gastrin-releasing peptide receptor at distinct sites. , 1996, Molecular pharmacology.
[257] L. Gozzini,et al. Bombesin receptor antagonists. , 1996, Critical reviews in oncology/hematology.
[258] G. Nussdorfer,et al. The role of neuromedin B in the regulation of rat pituitary-adrenocortical function. , 1996, Histology and histopathology.
[259] T. Seufferlein,et al. Reduced Requirement of Mitogen-activated Protein Kinase (MAPK) Activity for Entry into the S Phase of the Cell Cycle in Swiss 3T3 Fibroblasts Stimulated by Bombesin and Insulin* , 1996, The Journal of Biological Chemistry.
[260] J. Fehrentz,et al. JMV641: A potent bombesin receptor antagonist that inhibits Swiss 3T3 cell proliferation , 1996, Regulatory Peptides.
[261] T. Moran,et al. Receptor subtype mediation of feeding suppression by bombesin-like peptides , 1996, Pharmacology Biochemistry and Behavior.
[262] D. Venzon,et al. Somatostatin Receptor Scintigraphy: Its Sensitivity Compared with That of Other Imaging Methods in Detecting Primary and Metastatic Gastrinomas: A Prospective Study , 1996, Annals of Internal Medicine.
[263] J. Taylor,et al. Hindbrain GRP receptor blockade antagonizes feeding suppression by peripherally administered GRP. , 1996, The American journal of physiology.
[264] J. Taylor,et al. Pharmacological profiles of two bombesin analogues in cells transfected with human neuromedin B receptors. , 1996, European journal of pharmacology.
[265] J. Parsons,et al. p130Cas, a Substrate Associated with v-Src and v-Crk, Localizes to Focal Adhesions and Binds to Focal Adhesion Kinase* , 1996, The Journal of Biological Chemistry.
[266] J. Polak,et al. Role of Neuromedin B in the In Vitro Thyrotropin Release in Response to Thyrotropin-Releasing Hormone from Anterior Pituitaries of Eu-, Hypo-, and Hyperthyroid Rats , 1996, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.
[267] B. Gibson,et al. There Are Three Distinct Forms of Bombesin , 1996, The Journal of Biological Chemistry.
[268] S. O’Grady,et al. Regulation of colonic ion transport by GRP. I. GRP stimulates transepithelial K and Na secretion. , 1996, The American journal of physiology.
[269] S. Gregersen,et al. Studies on the Mechanisms by Which Gastrin Releasing Peptide Potentiates Glucose‐Induced Insulin Secretion from Mouse Islets , 1996, Pancreas.
[270] T. Moody,et al. Neuromedin B stimulates arachidonic acid release, c-fos gene expression, and the growth of C6 glioma cells , 1995, Peptides.
[271] R. Jensen,et al. Comparison of the peptide structural requirements for high affinity interaction with bombesin receptors. , 1995, European journal of pharmacology.
[272] E. Rozengurt,et al. Mitogenic signaling by transfected neuromedin B receptors in Rat-1 cells. , 1995, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.
[273] A. Schally,et al. Antagonists of bombesin/gastrin‐releasing peptide inhibit growth of SW‐1990 human pancreatic adenocarcinoma and production of cyclic AMP , 1995, International journal of cancer.
[274] R. Jensen,et al. Peptide structural requirements for antagonism differ between the two mammalian bombesin receptor subtypes. , 1995, The Journal of pharmacology and experimental therapeutics.
[275] C. Van Renterghem,et al. Properties and functions of a neuromedin-B-preferring bombesin receptor in brain microvascular endothelial cells. , 1995, European journal of biochemistry.
[276] R. T. Jensen,et al. Mammalian bombesin receptors , 1995, Medicinal research reviews.
[277] T. Fukai,et al. Non-peptide bombesin receptor antagonists, kuwanon G and H, isolated from mulberry. , 1995, Biochemical and biophysical research communications.
[278] K. Detjen,et al. Carboxyl-terminal Domains Determine Internalization and Recycling Characteristics of Bombesin Receptor Chimeras (*) , 1995, The Journal of Biological Chemistry.
[279] C. Logsdon,et al. Influence of Second and Third Cytoplasmic Loops on Binding, Internalization, and Coupling of Chimeric Bombesin/m3 Muscarinic Receptors (*) , 1995, The Journal of Biological Chemistry.
[280] Ian Foracs. Physiology of the Gastrointestinal Tract (3rd ed) , 1995 .
[281] B. Evers,et al. Role of Bombesin on Gut Mucosal Growth , 1995, Annals of surgery.
[282] R. Jensen,et al. Characterization of gastrin-releasing peptide receptor expressed in Sf9 insect cells by baculovirus. , 1995, Biochemistry.
[283] E. Spindel,et al. Cloning of a receptor for amphibian [Phe13]bombesin distinct from the receptor for gastrin-releasing peptide: identification of a fourth bombesin receptor subtype (BB4). , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[284] J. Primrose,et al. High-affinity binding sites for gastrin-releasing peptide on human colorectal cancer tissue but not uninvolved mucosa. , 1995, British Journal of Cancer.
[285] J. Battey,et al. The Gastrin-releasing Peptide Receptor Is Rapidly Phosphorylated by a Kinase Other Than Protein Kinase C After Exposure to Agonist (*) , 1995, The Journal of Biological Chemistry.
[286] R. Feldman,et al. Differential activation of human gastrin-releasing peptide receptor-mediated responses by bombesin analogs. , 1995, Molecular pharmacology.
[287] David C. orwell. The ‘peptoid’ approach to the design of non-peptide, small molecule agonists and antagonists of neuropeptides , 1995 .
[288] D. Payan,et al. Direct Observation of Endocytosis of Gastrin Releasing Peptide and Its Receptor (*) , 1995, The Journal of Biological Chemistry.
[289] D. Coy,et al. Fourth ventricular injection of the bombesin receptor antagonist [d-phe6]bombesin(6–13)methyl ester, but not BW2258U89, increases food intake in rats , 1995, Pharmacology Biochemistry and Behavior.
[290] R. Jensen,et al. Chronic Desensitization and Down-regulation of the Gastrin-releasing Peptide Receptor Are Mediated by a Protein Kinase C-dependent Mechanism (*) , 1995, The Journal of Biological Chemistry.
[291] T. Moody,et al. BW2258U89: a GRP receptor antagonist which inhibits small cell lung cancer growth. , 1995, Life sciences.
[292] A. Schally,et al. Potent bombesin antagonists with C-terminal Leu-psi(CH2-N)-Tac-NH2 or its derivatives. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[293] J. Taylor,et al. Blockade of feeding inhibition by neuromedin B using a selective receptor antagonist. , 1994, European journal of pharmacology.
[294] R. Jensen,et al. Glycosylation of bombesin receptors: characterization, effect on binding, and G-protein coupling. , 1994, Biochemistry.
[295] E. Spindel,et al. A rhesus monkey model to characterize the role of gastrin-releasing peptide (GRP) in lung development. Evidence for stimulation of airway growth. , 1994, The Journal of clinical investigation.
[296] A. Schally,et al. Bombesin antagonists inhibit in vitro and in vivo growth of human gastric cancer and binding of bombesin to its receptors , 1994, Journal of Cancer Research and Clinical Oncology.
[297] R. Jensen,et al. Internalization of the gastrin-releasing peptide receptor is mediated by both phospholipase C-dependent and -independent processes. , 1994, Molecular pharmacology.
[298] L. Slice,et al. The conserved NPXnY motif present in the gastrin-releasing peptide receptor is not a general sequestration sequence. , 1994, The Journal of biological chemistry.
[299] T. Reynolds,et al. Different types of bombesin receptors on neurons in the dorsal raphe nucleus and the rostral hypothalamus in rat brain slices in vitro , 1994, Brain Research.
[300] H. Parkman,et al. Pharmacological analysis of receptors for bombesin-related peptides on guinea pig gallbladder smooth muscle , 1994, Regulatory Peptides.
[301] R. Jensen,et al. Gastrin-releasing peptide receptor-induced internalization, down-regulation, desensitization, and growth: possible role for cyclic AMP. , 1994, Molecular pharmacology.
[302] J. Battey,et al. Neuromedin B receptor, expressed in Xenopus laevis oocytes, selectively couples to Gαq and not Gα11 , 1994 .
[303] A. Schally,et al. Characterization of high‐affinity receptors for bombesin/gastrin releasing peptide on the human prostate cancer cell lines PC‐3 and DU‐145: Internalization of receptor bound 125I‐(Tyr4) bombesin by tumor cells , 1994, The Prostate.
[304] T. Kirkham,et al. A novel bombesin receptor antagonist selectively blocks the satiety action of peripherally administered bombesin , 1994, Pharmacology Biochemistry and Behavior.
[305] J. Siegfried,et al. Expression of mRNA for three bombesin receptor subtypes in human bronchial epithelial cells. , 1994, American journal of respiratory cell and molecular biology.
[306] R. Jensen,et al. Desensitization of neuromedin B receptors (NMB-R) on native and NMB-R-transfected cells involves down-regulation and internalization. , 1994, The Journal of biological chemistry.
[307] K. Grzeschik,et al. Organization and chromosomal localization of the gene for the human bombesin receptor subtype expressed in pregnant uterus , 1994, FEBS letters.
[308] W. Sadee,et al. Overlapping multi-site domains of the muscarinic cholinergic Hm1 receptor involved in signal transduction and sequestration. , 1994, The Journal of biological chemistry.
[309] R. Plevin,et al. Rapid desensitization and resensitization of bombesin-stimulated phospholipase D activity in Swiss 3T3 cells. , 1994, The Biochemical journal.
[310] A. Schonbrunn,et al. Bombesin receptors in a human duodenal tumor cell line: binding properties and function. , 1994, Cancer research.
[311] S. Guard,et al. Rational design of high affinity tachykinin NK2 receptor antagonists. , 1994, Bioorganic & medicinal chemistry.
[312] Á. Hernanz,et al. Bombesin, gastrin-releasing peptide, and neuromedin C modulate murine lymphocyte proliferation through adherent accessory cells and activate protein kinase C , 1994, Peptides.
[313] C. Turner. Paxillin: A cytoskeletal target for tyrosine kinases , 1994, BioEssays : news and reviews in molecular, cellular and developmental biology.
[314] Á. Hernanz,et al. Stimulation of natural killer and antibody-dependent cellular cytotoxicity activities in mouse leukocytes by bombesin, gastrin-releasing peptide and neuromedin C: Involvement of cyclic AMP, inositol 1,4,5-trisphosphate and protein kinase C , 1993, Journal of Neuroimmunology.
[315] W. Sadee,et al. Hydrophobic amino acid in the i2 loop plays a key role in receptor-G protein coupling. , 1993, The Journal of biological chemistry.
[316] R. Jensen,et al. Discovery of a novel class of neuromedin B receptor antagonists, substituted somatostatin analogues. , 1993, Molecular pharmacology.
[317] R. Jensen,et al. Serines and threonines in the gastrin-releasing peptide receptor carboxyl terminus mediate internalization. , 1993, The Journal of biological chemistry.
[318] M. Bouzyk,et al. Homologous desensitization of bombesin‐induced increases in intracellular Ca2+ in quiescent swiss 3T3 cells involves a protein kinase C‐independent mechanism , 1993, Journal of cellular physiology.
[319] J. Benovic,et al. Mechanism of beta-adrenergic receptor kinase activation by G proteins. , 1993, The Journal of biological chemistry.
[320] R. Jensen,et al. The fifth transmembrane segment of the neuromedin B receptor is critical for high affinity neuromedin B binding. , 1993, The Journal of biological chemistry.
[321] Á. Valverde,et al. Bombesin stimulation of p125 focal adhesion kinase tyrosine phosphorylation. Role of protein kinase C, Ca2+ mobilization, and the actin cytoskeleton. , 1993, The Journal of biological chemistry.
[322] G. Maslen,et al. Comparative mapping of the Grpr locus on the X chromosomes of man and mouse. , 1993, Genomics.
[323] E. Sausville,et al. Neuromedin-B receptor transfected BALB/3T3 cells: signal transduction and effects of ectopic receptor expression on cell growth , 1993, Regulatory Peptides.
[324] J. Siegfried,et al. Effects of bombesin and gastrin‐releasing peptide on human bronchial epithelial cells from a series of donors: Individual variation and modulation by bombesin analogs , 1993, The Anatomical record.
[325] R. Jensen,et al. Characterization of bombesin receptors using a novel, potent, radiolabeled antagonist that distinguishes bombesin receptor subtypes. , 1993, Molecular pharmacology.
[326] R. Jensen,et al. Bombesin receptor antagonists differentiate receptor subtypes in rat brain. , 1993, European journal of pharmacology.
[327] E. Sausville,et al. BRS-3: a novel bombesin receptor subtype selectively expressed in testis and lung carcinoma cells. , 1993, The Journal of biological chemistry.
[328] D. Rees,et al. Cholecystokinin dipeptoid antagonists: design, synthesis, and anxiolytic profile of some novel CCK-A and CCK-B selective and "mixed" CCK-A/CCK-B antagonists. , 1993, Journal of medicinal chemistry.
[329] B. Stockstill,et al. Development of potent gastrin-releasing peptide antagonists having a D-Pro-psi(CH2NH)-Phe-NH2 C terminus. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[330] H. Verspaget,et al. Neuroenteric peptides affect natural killer activity by intestinal lamina propria mononuclear cells , 1993, Journal of Neuroimmunology.
[331] P. Mantyh,et al. Bombesin/GRP-preferring and neuromedin B-preferring receptors in the rat urogenital system , 1993, Neuropeptides.
[332] R. Jensen,et al. Ligand binding, internalization, degradation and regulation by guanine nucleotides of bombesin receptor subtypes: a comparative study. , 1993, Biochimica et biophysica acta.
[333] R. Jensen,et al. Neuromedin B receptors retain functional expression when transfected into BALB 3T3 fibroblasts: analysis of binding, kinetics, stoichiometry, modulation by guanine nucleotide-binding proteins, and signal transduction and comparison with natively expressed receptors. , 1992, Molecular pharmacology.
[334] R. Jensen,et al. Distinct distribution of two bombesin receptor subtypes in the rat central nervous system , 1992, Brain Research.
[335] D. Metz,et al. Thapsigargin defines the roles of cellular calcium in secretagogue-stimulated enzyme secretion from pancreatic acini. , 1992, The Journal of biological chemistry.
[336] B. Stockstill,et al. Conveyance of partial agonism/antagonism to bombesin/gastrin-releasing peptide analogues on Swiss 3T3 cells by a carboxyl-terminal leucine insertion. , 1992, The Journal of biological chemistry.
[337] R. Jensen,et al. Neuromedin B binds with high affinity, elevates cytosolic calcium and stimulates the growth of small-cell lung cancer cell lines. , 1992, The Journal of pharmacology and experimental therapeutics.
[338] R. Jensen,et al. Activation of neuromedin B-preferring bombesin receptors on rat glioblastoma C-6 cells increases cellular Ca2+ and phosphoinositides. , 1992, The Biochemical journal.
[339] F. Fahrenholz,et al. Molecular cloning of a new bombesin receptor subtype expressed in uterus during pregnancy. , 1992, European journal of biochemistry.
[340] J. Smyth,et al. Broad spectrum neuropeptide antagonists inhibit the growth of small cell lung cancer in vivo. , 1992, Cancer research.
[341] D. Coy,et al. Identification and initial characterization of a putative neuromedin B-type receptor from rat urinary bladder membranes. , 1992, European journal of pharmacology.
[342] C. Maggi,et al. Effect of [D-Phe6] bombesin (6-13) methylester, a bombesin receptor antagonist, towards bombesin-induced contractions in the guinea-pig and rat isolated urinary bladder. , 1992, Journal of autonomic pharmacology.
[343] J. Leban,et al. A novel bombesin receptor antagonist (2258U89), potently inhibits bombesin evoked release of gastrointestinal hormones from rats and dogs, in vitro and in vivo , 1992, Regulatory Peptides.
[344] R. Jensen,et al. Development of a potent bombesin receptor antagonist with prolonged in vivo inhibitory activity on bombesin-stimulated amylase and protein release in the rat , 1992, Peptides.
[345] D. Hill,et al. Mitogenic action of gastrin-releasing polypeptide on isolated epiphyseal growth plate chondrocytes from the ovine fetus. , 1992, Endocrinology.
[346] D. Withers,et al. Evidence for neuromedin-B synthesis in the rat anterior pituitary gland. , 1992, Endocrinology.
[347] J. Polak,et al. Role of neuromedin B in control of the release of thyrotropin in hypothyroid and hyperthyroid rats. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[348] M. Wakelam,et al. Bombesin stimulates the rapid activation of phospholipase A2-catalyzed phosphatidylcholine hydrolysis in Swiss 3T3 cells. , 1992, The Journal of biological chemistry.
[349] A. Gazdar,et al. Characterization of functional receptors for gastrointestinal hormones on human colon cancer cells. , 1992, Cancer research.
[350] A. Schally,et al. Pseudononapeptide bombesin antagonists containing C-terminal Trp or Tpi , 1992, Peptides.
[351] S. Narayan,et al. A potent bombesin receptor antagonist inhibits bombesin-stimulated growth of mouse colon cancer cells in vitro: absence of autocrine effects. , 1992, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.
[352] J. Battey,et al. Two distinct receptor subtypes for mammalian bombesin-like peptides , 1991, Trends in Neurosciences.
[353] S. Cook,et al. The regulation of phospholipase D activity and its role in sn-1,2-diradylglycerol formation in bombesin- and phorbol 12-myristate 13-acetate-stimulated Swiss 3T3 cells. , 1991, The Biochemical journal.
[354] A. Schally,et al. Inhibition of growth of HT-29 human colon cancer xenografts in nude mice by treatment with bombesin/gastrin releasing peptide antagonist (RC-3095). , 1991, Cancer research.
[355] H. Yamamoto,et al. Bombesin and bradykinin increase inositol phosphates and cytosolic free Ca2+, and stimulate DNA synthesis in human endometrial stromal cells. , 1991, The Journal of endocrinology.
[356] E. Sausville,et al. Two distinct bombesin receptor subtypes are expressed and functional in human lung carcinoma cells. , 1991, The Journal of biological chemistry.
[357] R. Jensen,et al. Covalently cyclized agonist and antagonist analogues of bombesin and related peptides. , 1991, The Journal of biological chemistry.
[358] D. Coy,et al. Comparison of prolonged in vivo inhibitory activity of several potent bombesin (BN) antagonists on BN-stimulated amylase secretion in the rat , 1991, Peptides.
[359] B. Göke,et al. Binding, internalization, and processing of bombesin by rat pancreatic acini. , 1991, The American journal of physiology.
[360] D. Heimbrook,et al. Gastrin releasing peptide antagonists with improved potency and stability. , 1991, Journal of medicinal chemistry.
[361] T. Matozaki,et al. Intracellular mediators of bombesin action on rat pancreatic acinar cells. , 1991, The American journal of physiology.
[362] M. De la Fuente,et al. Modulation of phagocytic function in murine peritoneal macrophages by bombesin, gastrin-releasing peptide and neuromedin C. , 1991, Immunology.
[363] R. Jensen,et al. Different receptors mediate the action of bombesin-related peptides on gastric smooth muscle cells. , 1991, The American journal of physiology.
[364] D. Coy,et al. Effects of potent bombesin antagonist on exocrine pancreatic secretion in rats , 1991, Peptides.
[365] R. Jensen,et al. cDNA cloning, characterization, and brain region-specific expression of a neuromedin-B-preferring bombesin receptor , 1991, Neuron.
[366] C. Denef,et al. Effect of the bombesin receptor blockers [Leu13,ψCH2NH-Leu14]bombesin and N-pivaloyl GRP(20–25) alkylamide (L 686,095-001C002) on basal and neuromedin C-stimulated PRL and GH release in pituitary cell aggregates , 1991, Peptides.
[367] K. Patel,et al. Modulation of inositol lipid hydrolysis in human breast cancer cells by two classes of bombesin antagonist. , 1991, Journal of molecular endocrinology.
[368] R. Feldman,et al. Molecular cloning of the bombesin/gastrin-releasing peptide receptor from Swiss 3T3 cells. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[369] R. Jensen,et al. Reduced peptide bond pseudopeptide analogues of secretin. A new class of secretin receptor antagonists. , 1991, The Journal of biological chemistry.
[370] P. McHugh,et al. Receptor heterogeneity for bombesin-like peptides in the rat central nervous system , 1990, Brain Research.
[371] P. Brehm,et al. Cloning and functional characterization of a complementary DNA encoding the murine fibroblast bombesin/gastrin-releasing peptide receptor. , 1990, Molecular endocrinology.
[372] L. Wang,et al. Short chain bombesin pseudopeptides with potent bombesin receptor antagonist activity in rat and guinea pig pancreatic acinar cells. , 1990, European journal of pharmacology.
[373] R. Jensen,et al. Characterization of the bombesin receptor on mouse pancreatic acini by chemical cross-linking , 1990, Peptides.
[374] R. Feldman,et al. Purification and characterization of the bombesin/gastrin-releasing peptide receptor from Swiss 3T3 cells. , 1990, The Journal of biological chemistry.
[375] R. Jensen,et al. des-Met carboxyl-terminally modified analogues of bombesin function as potent bombesin receptor antagonists, partial agonists, or agonists. , 1990, The Journal of biological chemistry.
[376] R. Jensen,et al. Potent bombesin receptor antagonists distinguish receptor subtypes. , 1990, The American journal of physiology.
[377] E. Wada,et al. Neuromedin B and gastrin-releasing peptide mRNAs are differentially distributed in the rat nervous system , 1990, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[378] J. Millar,et al. Chronic desensitization to bombesin by progressive down-regulation of bombesin receptors in Swiss 3T3 cells. Distinction from acute desensitization. , 1990, The Journal of biological chemistry.
[379] M. Sheppard,et al. Expression of gastrin‐releasing peptide (human bombesin) gene in large cell undifferentiated carcinoma of the lung , 1990, The Journal of pathology.
[380] S. Swope,et al. Desensitization of islet cells to bombesin involves both receptor down-modulation and inhibition of receptor function. , 1990, Molecular pharmacology.
[381] M. Sporn,et al. Peptide Growth Factors and Their Receptors I , 1990, Handbook of Experimental Pharmacology.
[382] K. Hermansen,et al. Gastrin releasing peptide stimulates the secretion of insulin, but not that of glucagon or somatostatin, from the isolated perfused dog pancreas. , 1990, Acta physiologica Scandinavica.
[383] R. Jensen,et al. Desmethionine alkylamide bombesin analogues: a new class of bombesin receptor antagonists with potent antisecretory activity in pancreatic acini and antimitotic activity in Swiss 3T3 cells. , 1990, Biochemistry.
[384] R. Jensen,et al. Reduced peptide bond pseudopeptide analogues of substance P. A new class of substance P receptor antagonists with enhanced specificity. , 1989, The Journal of biological chemistry.
[385] R. Jensen,et al. Short-chain pseudopeptide bombesin receptor antagonists with enhanced binding affinities for pancreatic acinar and Swiss 3T3 cells display strong antimitotic activity. , 1989, The Journal of biological chemistry.
[386] D. Heimbrook,et al. Carboxyl-terminal modification of a gastrin releasing peptide derivative generates potent antagonists. , 1989, The Journal of biological chemistry.
[387] R. Jensen,et al. Effect of substitutions in position 12 of bombesin on antagonist activity , 1989, Peptides.
[388] R. Jensen,et al. Neuromedin B receptor in esophagus: evidence for subtypes of bombesin receptors. , 1989, The American journal of physiology.
[389] S. Wank,et al. Regulation of bombesin receptors on pancreatic acini by cholecystokinin. , 1989, The American journal of physiology.
[390] K. Dickinson,et al. Partial agonist activity of the bombesin-receptor antagonist [Leu14-psi-CH2-NH-Leu13]-bombesin in frog peptic cells. , 1988, Biochemical and biophysical research communications.
[391] E. Rozengurt. Bombesin‐Induction of Cell Proliferation in 3T3 Cells , 1988, Annals of the New York Academy of Sciences.
[392] Eliot R. Spindel,et al. Report and Recommendations 14 October 1987 , 1988 .
[393] N. Rhaleb,et al. Receptors for Neurokinins, Tachykinins, and Bombesin: A Pharmacological Study a , 1988 .
[394] R. Jensen,et al. Interaction of Bombesin and Related Peptides with Receptors on Pancreatic Acinar Cells , 1988, Annals of the New York Academy of Sciences.
[395] I. Hramiak,et al. The Effect of Gastrin‐Releasing Peptide on the Endocrine Pancreas a , 1988, Annals of the New York Academy of Sciences.
[396] T. O'donohue,et al. Localization of Receptors for Bombesin‐like Peptides in the Rat Brain 1 , 1988, Annals of the New York Academy of Sciences.
[397] V. Erspamer. Discovery, Isolation, and Characterization of Bombesin‐like Peptides , 1988 .
[398] P. Panula,et al. Localization and Development of Bombesin/GRP‐like Immunoreactivity in the Rat Central Nervous System a , 1988, Annals of the New York Academy of Sciences.
[399] J. Gibbs,et al. The Actions of Bombesin‐like Peptides on Food Intake a , 1988, Annals of the New York Academy of Sciences.
[400] E. Rozengurt,et al. Characterization of a bombesin receptor on Swiss mouse 3T3 cells by affinity cross‐linking , 1988, Journal of cellular biochemistry.
[401] E. Sausville,et al. A novel bombesin receptor antagonist inhibits autocrine signals in a small cell lung carcinoma cell line. , 1988, Biochemical and biophysical research communications.
[402] J. Millar,et al. Bombesin enhancement of cAMP accumulation in swiss 3T3 cells: Evidence of a dual mechanism of action , 1988, Journal of cellular physiology.
[403] R. Jensen,et al. An analogue of substance P with broad receptor antagonist activity. , 1988, Biochimica et biophysica acta.
[404] T. Matozaki,et al. Somatostatin receptors on rat cerebrocortical membranes. Structural characterization of somatostatin-14 and somatostatin-28 receptors and comparison with pancreatic type receptors. , 1988, The Journal of biological chemistry.
[405] P. Woll,et al. Bombesin and bombesin antagonists: studies in Swiss 3T3 cells and human small cell lung cancer. , 1988, British Journal of Cancer.
[406] R. Jensen,et al. Characterization of ability of various substance P antagonists to inhibit action of bombesin. , 1988, The American journal of physiology.
[407] V. Garsky,et al. Minimal Ligand Analysis of Gastrin‐Releasing Peptide: Receptor Binding and Mitogenesis , 1988, The Journal of biological chemistry.
[408] A. N. Corps,et al. Characterization of the high-affinity receptors on Swiss 3T3 cells which mediate the binding, internalization and degradation of the mitogenic peptide bombesin. , 1988, The Biochemical journal.
[409] C. Severini,et al. Parallel bioassay of 27 bombesin-like peptides on 9 smooth muscle preparations. Structure-activity relationships and bombesin receptor subtypes , 1988, Regulatory Peptides.
[410] R. Jensen,et al. Probing peptide backbone function in bombesin. A reduced peptide bond analogue with potent and specific receptor antagonist activity. , 1988, The Journal of biological chemistry.
[411] M. Nakamura,et al. Autoradiographic demonstration of gastrin-releasing peptide-binding sites in the rat gastric mucosa. , 1988, Gastroenterology.
[412] P. Woll,et al. [D-Arg1,D-Phe5,D-Trp7,9,Leu11]substance P, a potent bombesin antagonist in murine Swiss 3T3 cells, inhibits the growth of human small cell lung cancer cells in vitro. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[413] K. Kawai,et al. Effects of neuromedin B, gastrin-releasing peptide-10 and their fragment peptides on secretion of gastrointestinal and pancreatic hormones in dogs. , 1988, Acta endocrinologica.
[414] K. Gautvik,et al. Bombesin stimulates prolactin secretion from cultured rat pituitary tumour cells (GH4C1) via activation of phospholipase C , 1987, Regulatory Peptides.
[415] S. Swope,et al. Characterization of ligand binding and processing by bombesin receptors in an insulin-secreting cell line. , 1987, The Biochemical journal.
[416] T. Moody,et al. Identification of the bombesin-receptor on murine and human cells by cross-linking experiments , 1987, Regulatory Peptides.
[417] E. Rozengurt,et al. Internalization and degradation of peptides of the bombesin family in Swiss 3T3 cells occurs without ligand‐induced receptor down‐regulation. , 1987, The EMBO journal.
[418] D. Coy,et al. Solid-phase synthesis and biological properties of psi [CH2NH] pseudopeptide analogues of a highly potent somatostatin octapeptide. , 1987, Journal of medicinal chemistry.
[419] M. Collins,et al. Protein kinase C activation enhances cAMP accumulation in Swiss 3T3 cells: inhibition by pertussis toxin. , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[420] A. Giraud,et al. Bombesin stimulation of gastrin release from canine gastrin cells in primary culture. , 1987, The American journal of physiology.
[421] R. Jensen,et al. [D-Phe12]bombesin analogues: a new class of bombesin receptor antagonists. , 1987, The American journal of physiology.
[422] B. Ahrén,et al. Gastrin Releasing Peptide (GRP): Effects on basal and stimulated insulin and glucagon secretion in the mouse , 1987, Peptides.
[423] G. Greeley,et al. Effect of Bombesin and Gastrin-Releasing Peptide on the Release of Gastric Inhibitory Polypeptide and Insulin in Rats 1 , 1986, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.
[424] T. O'donohue,et al. Neuromedin B-like peptides in rat brain: Biochemical characterization, mechanism of release and localization in synaptosomes , 1986, Peptides.
[425] J. Bali,et al. Synthesis and biological activities of some pseudo-peptide analogues of tetragastrin: the importance of the peptide backbone. , 1985, Journal of medicinal chemistry.
[426] N. Minamino,et al. Neuromedin B-32 and B-30: two "big" neuromedin B identified in porcine brain and spinal cord. , 1985, Biochemical and biophysical research communications.
[427] J. Minna,et al. High affinity receptors for bombesin/GRP-like peptides on human small cell lung cancer. , 1985, Life sciences.
[428] N. Minamino,et al. Neuromedin B is a major bombesin-like peptide in rat brain: regional distribution of neuromedin B and neuromedin C in rat brain, pituitary and spinal cord. , 1984, Biochemical and biophysical research communications.
[429] J. Willey,et al. Bombesin and the C-terminal tetradecapeptide of gastrin-releasing peptide are growth factors for normal human bronchial epithelial cells. , 1984, Experimental cell research.
[430] R. Jensen,et al. A synthetic peptide that is a bombesin receptor antagonist , 1984, Nature.
[431] N. Minamino,et al. Neuromedin C: a bombesin-like peptide identified in porcine spinal cord. , 1984, Biochemical and biophysical research communications.
[432] F. Sundler,et al. Gastrin-releasing peptide (GRP) in neurones of the mammalian gut , 1983, Regulatory Peptides.
[433] L. Rees,et al. Distribution and characterisation of immunoreactive somatostatin in human gastrointestinal tract , 1983, Regulatory Peptides.
[434] N. Minamino,et al. Neuromedin B: a novel bombesin-like peptide identified in porcine spinal cord. , 1983, Biochemical and biophysical research communications.
[435] E. Rozengurt,et al. Bombesin stimulation of DNA synthesis and cell division in cultures of Swiss 3T3 cells. , 1983, Proceedings of the National Academy of Sciences of the United States of America.
[436] T. Adrian,et al. Dose-response comparisons of canine plasma gastroenteropancreatic hormone responses to bombesin and the porcine gastrin-releasing peptide (GRP) , 1983, Regulatory Peptides.
[437] R. Jensen,et al. Mechanism of [Tyr4]bombesin-induced desensitization in dispersed acini from guinea pig pancreas. , 1982, The Journal of biological chemistry.
[438] P. Panula,et al. Neuronal location of the bombesin-like immunoreactivity in the central nervous system of the rat , 1982, Regulatory Peptides.
[439] T. Adrian,et al. Bombesin: action on gut hormones and calcium in man. , 1982, The Journal of clinical endocrinology and metabolism.
[440] G. Mazzanti,et al. Relative potencies of porcine bombesin‐like heptacosapeptide (PB‐27), amphibian bombesin (B‐14) and litorin, and bombesin C‐terminal nonapeptide (B‐9) on in vitro and in vivo smooth muscle preparations , 1982, The Journal of pharmacy and pharmacology.
[441] J. Rivier,et al. Bombesin analogs: Effects on thermoregulation and glucose metabolism , 1981, Peptides.
[442] P. Newberne,et al. Working Group IV: lipids and the immune system. Report and recommendations. , 1981, Cancer research.
[443] P. D. Webster,et al. Pancreatic exocrine secretion. , 1981, Clinics in gastroenterology.
[444] V. Mutt,et al. A qualitative comparison of canine plasma gastroenteropancreatic hormone responses to bombesin and the porcine gastrin-releasing peptide (GRP) , 1981, Regulatory Peptides.
[445] Jensen Rt,et al. Identification and characterization of receptors for secretagogues on pancreatic acinar cells. , 1981 .
[446] J. Walsh,et al. Stimulation of canine pancreatic polypeptide, gastrin, and gastric acid secretion by ranatensin, litorin, bombesin nonapeptide and substance p , 1981, Regulatory Peptides.
[447] R. Jensen,et al. Bombesin-induced desensitization of enzyme secretion in dispersed acini from guinea pig pancreas. , 1980, The American journal of physiology.
[448] E. Rolls,et al. Bombesin suppresses feeding in rats , 1979, Nature.
[449] M. Nirenberg,et al. Muscarinic acetylcholine receptor regulation by accelerated rate of receptor loss. , 1979, Biochemical and biophysical research communications.
[450] G Nilsson,et al. Characterization of a gastrin releasing peptide from porcine non-antral gastric tissue. , 1979, Biochemical and biophysical research communications.
[451] C. Pert,et al. Interaction of bombesin and litorin with specific membrane receptors on pancreatic acinar cells. , 1978, Proceedings of the National Academy of Sciences of the United States of America.
[452] J. Rivier,et al. Bomebesin: specific binding to rat brain membranes. , 1978, Proceedings of the National Academy of Sciences of the United States of America.
[453] J. Rivier,et al. Bombesin, bombesin analogues, and related peptides: effects on thermoregulation. , 1978, Biochemistry.
[454] P. de Neef,et al. In vitro action of bombesin and bombesin-like peptides on amylase secretion, calcium efflux, and adenylate cyclase activity in the rat pancreas: a comparison with other secretagogues. , 1976, The Journal of clinical investigation.
[455] G. Erspamer,et al. RELATIVE POTENCY OF BOMBESIN‐LIKE PEPTIDES , 1975, British journal of pharmacology.
[456] V. Erspamer,et al. Active polypeptides of the amphibian skin and their synthetic analogues , 1973 .
[457] V. Erspamer,et al. Occurrence of bombesin and alytesin in extracts of the skin of three European discoglossid frogs and pharmacological actions of bombesin on extravascular smooth muscle , 1972, British journal of pharmacology.
[458] V. Erspamer,et al. Some pharmacological actions of alytesin and bombesin , 1970, The Journal of pharmacy and pharmacology.
[459] V. Bennett,et al. Gastrin Releasing Peptide , 2008 .
[460] E. Krenning,et al. Androgen-dependent expression of the gastrin-releasing peptide receptor in human prostate tumor xenografts. , 2007, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[461] R. Jensen,et al. Solubilization and purification of bombesin/gastrin releasing peptide receptors from human cell lines , 2007, Journal of Molecular Neuroscience.
[462] L. Strauss,et al. 68 Ga-Labeled Bombesin Studies in Patients with Gastrointestinal Stromal Tumors: Comparison with 18 F-FDG , 2007 .
[463] R. Jensen,et al. Bombesin/gastrin-releasing peptide receptor antagonists increase the ability of histone deacetylase inhibitors to reduce lung cancer proliferation , 2007, Journal of Molecular Neuroscience.
[464] F. Forrer,et al. Neuroendocrine tumors. Peptide receptor radionuclide therapy. , 2007, Best practice & research. Clinical endocrinology & metabolism.
[465] R. Benya,et al. Gastrin-releasing peptide mediates its morphogenic properties in human colon cancer by upregulating intracellular adhesion protein-1 (ICAM-1) via focal adhesion kinase. , 2007, American journal of physiology. Gastrointestinal and liver physiology.
[466] G. Baldwin,et al. Synthesis, expression and biological activity of the prohormone for gastrin releasing peptide (ProGRP). , 2006, Endocrinology.
[467] R. Jensen,et al. Bombesin-Related Peptides and Neurotensin: Effects on Cancer Growth/Proliferation and Cellular Signaling in Cancer , 2006 .
[468] J. Pittet,et al. Bombesin-like peptides: modulators of inflammation in acute lung injury? , 2006, American journal of respiratory and critical care medicine.
[469] A. Nunn,et al. Selective in vitro targeting of GRP and NMB receptors in human tumours with the new bombesin tracer 177Lu-AMBA , 2006, European Journal of Nuclear Medicine and Molecular Imaging.
[470] J. Parry,et al. MicroPET Imaging of Breast Cancer Using Radiolabeled Bombesin Analogs Targeting the Gastrin-releasing Peptide Receptor , 2006, Breast Cancer Research and Treatment.
[471] E. A. Bernard,et al. Gastrin-releasing peptide receptor antagonist effects on an animal model of sepsis. , 2006, American journal of respiratory and critical care medicine.
[472] R. Jensen,et al. Rottlerin inhibits stimulated enzymatic secretion and several intracellular signaling transduction pathways in pancreatic acinar cells by a non-PKC-delta-dependent mechanism. , 2006, Biochimica et biophysica acta.
[473] 中川 倫夫. Identification of key amino acids in the gastrin-releasing peptide receptor (GRPR) responsible for high affinity binding of gastrin-releasing peptide (GRP) , 2006 .
[474] A. Kastin. Handbook of biologically active peptides , 2006 .
[475] E. Spindel. Amphibian Bombesin-Like Peptides , 2006 .
[476] H. Ohki‐Hamazaki,et al. Development and function of bombesin-like peptides and their receptors. , 2005, The International journal of developmental biology.
[477] K. Wada,et al. Bombesin-like peptide receptor gene expression, regulation, and function in fetal murine lung. , 2004, American journal of physiology. Lung cellular and molecular physiology.
[478] L. Johnson. Encyclopedia of Gastroenterology , 2004 .
[479] J. Reubi,et al. Bombesin receptor subtypes in human cancers: detection with the universal radioligand (125)I-[D-TYR(6), beta-ALA(11), PHE(13), NLE(14)] bombesin(6-14). , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.
[480] K. Wada,et al. Role of bombesin (BN)-like peptides/receptors in emotional behavior by comparison of three strains of BN-like peptide receptor knockout mice , 2002, Molecular Psychiatry.
[481] Richard,et al. Purification and Characterization of the Bombesin / Gastrin-releasing Peptide Receptor from Swiss 3 T 3 Cells * , 2001 .
[482] Y. Taché,et al. Bombesin and the brain-gut axis. , 2000, Peptides.
[483] K. Grzeschik,et al. Significant association between a silent polymorphism in the neuromedin B gene and body weight in German children and adolescents , 2000, Acta Diabetologica.
[484] E. Rozengurt,et al. [D-Arg(1),D-Trp(5,7,9),Leu(11)]Substance P inhibits bombesin-induced mitogenic signal transduction mediated by both G(q) and G(12) in Swiss 3T3cells. , 2000, The Journal of biological chemistry.
[485] E. Rozengurt. G Protein-Coupled Receptors in Gastrointestinal Physiology V. Gastrointestinal peptide signaling through tyrosine phosphorylation of focal adhesion proteins * , 1998 .
[486] F. Sundler,et al. Insulin secretion by gastrin-releasing peptide in mice: ganglionic versus direct islet effect. , 1998, American journal of physiology. Endocrinology and metabolism.
[487] E. Rozengurt. V. Gastrointestinal peptide signaling through tyrosine phosphorylation of focal adhesion proteins. , 1998, The American journal of physiology.
[488] A. Schally,et al. GRHきっ坑薬のMZ‐5‐156は,ヌードマウスのDU‐145ヒトアンドロゲン非依存性前立腺癌の成長を阻害し,腫よう内のIGF2のレベル及びmRNA発現を低下させる , 1998 .
[489] J. Benovic,et al. The role of receptor kinases and arrestins in G protein-coupled receptor regulation. , 1998, Annual review of pharmacology and toxicology.
[490] K. Eguchi,et al. Serum levels of pro-gastrin-releasing peptide for follow-up of patients with small cell lung cancer. , 1997, Clinical cancer research : an official journal of the American Association for Cancer Research.
[491] J. Taylor,et al. Caudal hindbrain neuromedin B-preferring receptors participate in the control of food intake. , 1997, The American journal of physiology.
[492] N. Guex,et al. SWISS‐MODEL and the Swiss‐Pdb Viewer: An environment for comparative protein modeling , 1997, Electrophoresis.
[493] R. Jensen,et al. Bombesin/GRP and vasoactive intestinal peptide/PACAP as growth factors , 1996 .
[494] T. Moody,et al. GRP receptors are present in non small cell lung cancer cells , 1996, Journal of cellular biochemistry. Supplement.
[495] J. Knezetic,et al. Bombesin may stimulate proliferation of human pancreatic cancer cells through an autocrine pathway. , 1996, International journal of cancer.
[496] E. Sausville,et al. Bombesin receptor structure and expression in human lung carcinoma cell lines , 1996, Journal of cellular biochemistry. Supplement.
[497] B. Gibson,et al. There Are Three Distinct Forms of Bombesin IDENTIFICATION OF [Leu 13 ]BOMBESIN, [Phe 13 ]BOMBESIN, AND [Ser 3 ,Arg 10 ,Phe 13 ]BOMBESIN IN THE FROG BOMBINA ORIENTALIS * , 1996 .
[498] J. Kebabian,et al. The Sigma-RBI handbook of receptor classification and signal transduction , 1995 .
[499] R. Jensen,et al. Expression and characterization of cloned human bombesin receptors. , 1995, Molecular pharmacology.
[500] D. Horwell. The 'peptoid' approach to the design of non-peptide, small molecule agonists and antagonists of neuropeptides. , 1995, Trends in biotechnology.
[501] P. Hawkins,et al. Activation of the small GTP-binding proteins rho and rac by growth factor receptors. , 1995, Journal of cell science.
[502] M. Brattain,et al. Chapter 14 – Role of Autocrine Growth Factors in Cancer Cells , 1994 .
[503] M. Del Río,et al. Chemoattractant capacity of bombesin, gastrin-releasing peptide and neuromedin C is mediated through PKC activation in murine peritoneal leukocytes. , 1994, Regulatory peptides.
[504] W. Howson,et al. 'Peptoid' design. , 1994, Drug design and discovery.
[505] R. Jensen,et al. Bombesin receptor antagonists: different classes and cellular basis of action. , 1993, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.
[506] E. Spindel,et al. Bombesin-like peptides: of ligands and receptors. , 1993, Recent progress in hormone research.
[507] R. Jensen,et al. 14 - Distinguishing Bombesin Receptor Subtypes , 1993 .
[508] T. Moran,et al. Receptors for Bombesin-like Peptides in the Rat Central Nervous System , 1993 .
[509] R. Jensen,et al. Systematic development of bombesin/gastrin-releasing peptide antagonists. , 1992, Journal of the National Cancer Institute. Monographs.
[510] H. Shapira,et al. Molecular genetic analysis of two distinct receptors for mammalian bombesin-like peptides. , 1992, Journal of the National Cancer Institute. Monographs.
[511] R. Jensen,et al. Progress in the development of potent bombesin receptor antagonists. , 1991, Trends in pharmacological sciences.
[512] G. Makhlouf,et al. Regulation of acid secretion by bombesin/GRP neurons of the gastric fundus. , 1991, The American journal of physiology.
[513] J. Gardner,et al. Carbachol desensitizes pancreatic enzyme secretion by downregulation of receptors. , 1990, The American journal of physiology.
[514] James F. Battey,et al. Peptide growth factors and their receptors , 1990 .
[515] C. F. Hayward,et al. N-isobutyryl-His-Trp-Ala-Val-D-Ala-His-Leu-NHMe (ICI 216140) a potent in vivo antaconist analogue of bombesin/gastrin releasing peptide (BN/GRP) derived from the C-terminal sequence lacking the final methionine residue. , 1989, Life sciences.
[516] Disease,et al. Bombesin-like peptides in health and disease , 1988 .
[517] L. Kaplan,et al. Gastrin-releasing peptide (mammalian bombesin) gene expression in health and disease. , 1988, Laboratory investigation; a journal of technical methods and pathology.
[518] Bombesin-like peptides in health and disease. Nomenclature meeting. Report and recommendations. 14 October 1987. , 1988, Annals of the New York Academy of Sciences.
[519] John D. Minna,et al. Bombesin-like peptides can function as autocrine growth factors in human small-cell lung cancer , 1985, Nature.
[520] C. Pert,et al. Neuropeptides are chemoattractants for human tumor cells and monocytes: a possible mechanism for metastasis. , 1985, Clinical immunology and immunopathology.
[521] G. Habermehl,et al. ReviewPure appl. Chem: Rinehart, K. L., et al. Marine natural products as sources of antiviral, antimicrobial, and antineoplastic Agents. 53, 795 (1981). (K. L. Rinehart, University of Illinois, Urbana, IL 61801, U.S.A.) , 1983 .
[522] R. Jensen,et al. Identification and characterization of receptors for secretagogues on pancreatic acinar cells. , 1981, Federation proceedings.
[523] D. Elkind. Children and adolescents : interpretive essays on Jean Piaget , 1970 .